Progress: Procedure completed
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | CONT | ZDECHOVSKÝ Tomáš ( EPP) | CHINNICI Caterina ( S&D), STRUGARIU Ramona ( Renew), EICKHOUT Bas ( Verts/ALE), KUHS Joachim ( ID), CZARNECKI Ryszard ( ECR), OMARJEE Younous ( GUE/NGL) |
Committee Opinion | ENVI | ||
Committee Opinion | LIBE | STRUGARIU Ramona ( Renew) | Malin BJÖRK ( GUE/NGL), Peter KOFOD ( ID) |
Lead committee dossier:
Subjects
Events
The European Parliament decided by 636 votes to 53, with 9 abstentions, to give discharge to the Director of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for the financial year 2020 and to approve the closure of the accounts for that year.
Noting that the Court of Auditors stated that it had obtained reasonable assurance that the Centre's annual accounts for the financial year 2020 were reliable and that the underlying transactions were legal and regular, Parliament adopted, by 569 votes to 47 with 22 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
Centre’s financial statements
The EMCDDA's final budget for 2020 was EUR 18 048 883, representing a minimal decrease of 0.71 % compared to 2019.
Budgetary and financial management
Parliament welcomed the budget monitoring efforts made during the 2020 financial year, which resulted in a budget implementation rate of 100%, the same rate as in 2019. The payment appropriations execution rate was 94.73 %, representing a decrease of 3.56 % compared to the previous year.
Other observations
Members also made a series of observations concerning performance, staff, procurement and Covid-19.
In particular, they noted that:
- the Centre contributed to the development of the EU Agenda and Action Plan on Drugs 2021-2025;
- most of the Centre’s work in 2020 was dedicated to investigating the impact of Covid-19 on the drug situation in Europe and that the Centre launched twelve new resources in 2020, including special reports and web pages, in an effort to timely contribute with information and resources to the fight against the pandemic;
- on 31 December 2020, the establishment plan was 93.69 % implemented, with seven officials and 62 temporary agents appointed out of 10 officials and 66 temporary agents authorised under the Union budget;
- the Centre should rely as much as possible on permanent staff as opposed to external staff and interim workers. The Commission should ensure appropriate human resources allocations for that purpose;
- the lack of gender balance within senior management with two women and seven men and on its management board with 22 men and 10 women;
- the Centre concluded a service-level agreement in 2020 with the Commission’s Directorate-General for Informatics (DIGIT) for the provision of services relating to ICT procurement and e-procurement (e-Prior services);
- in terms of procurement execution, the 2020 procurement plan was put in place in line with the Centre’s 2020 management plan, and was successfully executed in close collaboration with all units;
- the Centre established a task force to coordinate the public health response to the pandemic in March 2020 after activating the Centre’s contingency management plan, and putting in place measures to ensure the safety of the staff and business continuity;
- the Centre has been actively monitoring its environmental performance and CO2 footprint. A considerable drop was noted for 2020 caused by a Covid-19 related reduction in missions and transport, as well as the Centre’s switch from to CO2 neutral electricity generated from renewable energy sources.
Documents
- Debate in Parliament: Debate in Parliament
- Decision by Parliament: T9-0157/2022
- Committee report tabled for plenary, single reading: A9-0118/2022
- Committee report tabled for plenary: A9-0118/2022
- Amendments tabled in committee: PE704.734
- Supplementary non-legislative basic document: 06003/2022
- Committee opinion: PE702.929
- Committee draft report: PE698.975
- Court of Auditors: opinion, report: OJ C 439 29.10.2021, p. 0003
- Court of Auditors: opinion, report: N9-0044/2022
- Non-legislative basic document: COM(2021)0381
- Non-legislative basic document: EUR-Lex
- Non-legislative basic document published: COM(2021)0381
- Non-legislative basic document published: EUR-Lex
- Non-legislative basic document: COM(2021)0381 EUR-Lex
- Court of Auditors: opinion, report: OJ C 439 29.10.2021, p. 0003 N9-0044/2022
- Committee draft report: PE698.975
- Supplementary non-legislative basic document: 06003/2022
- Committee opinion: PE702.929
- Amendments tabled in committee: PE704.734
- Committee report tabled for plenary, single reading: A9-0118/2022
Votes
Décharge 2020: Observatoire européen des drogues et des toxicomanies - Discharge 2020: European Monitoring Centre for Drugs and Drug Addiction - Entlastung 2020: Europäische Beobachtungsstelle für Drogen und Drogensucht - A9-0118/2022 - Tomáš Zdechovský - Proposition de résolution #
Amendments | Dossier |
9 |
2021/2133(DEC)
2022/01/20
LIBE
9 amendments...
Amendment 1 #
Draft opinion Paragraph -1 (new) -1. Highlights the important role of the European Monitoring Centre for Drugs and Drug Addiction (the 'Centre’) in providing policy-makers and practitioners with analyses and information concerning drugs and drug addiction as well as emerging trends with a view to effectively countering illicit drug use and trafficking and in contributing to a healthier Europe by addressing important drug-related public health concerns; recalls that drug trafficking has been identified as a main source of profit and a channel of recruitment for organised crime and terrorism, and therefore highlights the contribution of the Centre also to a more secure Europe;
Amendment 2 #
Draft opinion Paragraph 1 1. Welcomes the fact that the Court of Auditors (the ‘Court’) has declared the transactions underlying the annual accounts of the European Monitoring Centre for Drugs and Drug Addiction (the 'Centre’) for the financial year 2020 to be legal and regular in all material respects and that its financial position at 31 December 2020 is fairly presented; notes that its budget in 2020 increased from EUR 19 million to EUR 23 million (+21%) while its staff decreased from 107 to 102 (- 4.7%);
Amendment 3 #
Draft opinion Paragraph 3 3. Welcomes the setting up of the COVID-19 hub page to provide resources and raise awareness on the impact of the diseases on people who use drugs and drugs service providers, including prison services, as well as the 28 new projects designed by the Centre, 11 of which were focused on COVID-19;
Amendment 4 #
Draft opinion Paragraph 4 4. Notes with satisfaction the 35 publications by the Centre, including strategic and situational analyses and threat assessments, which inform policy and practice; welcomes the close cooperation between the Centre and other Justice and Home Affairs (JHA) agencies, such as European Union Agency for Fundamental Rights and Europol, and the joint publications issued in 2020;
Amendment 5 #
Draft opinion Paragraph 5 5. Welcomes the organisation of the 2020 European Drugs Summer School in a fully digital format, attracting 49 participants from 30 countries; considers it crucial in order to continue raising awareness of the importance that all drugs policies have a prevention and mental-health-based approach;
Amendment 6 #
Draft opinion Paragraph 5 5.
Amendment 7 #
Draft opinion Paragraph 5 a (new) Amendment 8 #
Draft opinion Paragraph 5 a (new) 5 a. Highlights the contribution of the Centre, by means of its annual reports, to the development of the EU Agenda and Action Plan on Drugs 2021-2025, and the role the Centre is going to play in its implementation;
Amendment 9 #
Draft opinion Paragraph 5 b (new) 5 b. Welcomes the Centre’s cooperation with other agencies and its contribution to the JHA agencies’ network;
source: 704.539
|
History
(these mark the time of scraping, not the official date of the change)
events/4/docs |
|
events/6 |
|
procedure/final |
|
procedure/stage_reached |
Old
Procedure completed, awaiting publication in Official JournalNew
Procedure completed |
events/0 |
|
events/3 |
|
docs/1 |
|
events/0 |
|
events/3 |
|
events/5/docs/0/url |
https://www.europarl.europa.eu/doceo/document/TA-9-2022-0157_EN.html
|
docs/6 |
|
events/5/summary |
|
procedure/subject/8.70.03.10 |
2020 discharge
|
docs/0 |
|
docs/0 |
|
docs/5 |
|
docs/6 |
|
events/0 |
|
events/0 |
|
events/3/docs |
|
events/4 |
|
events/5 |
|
forecasts |
|
procedure/stage_reached |
Old
Awaiting Parliament's voteNew
Procedure completed, awaiting publication in Official Journal |
procedure/subject/8.70.03.10 |
2020 discharge
|
forecasts |
|
forecasts |
|
events/3 |
|
procedure/stage_reached |
Old
Awaiting committee decisionNew
Awaiting Parliament's vote |
events/2 |
|
procedure/Other legal basis |
Rules of Procedure EP 159
|
docs/2 |
|
docs/3/docs/0/url |
https://www.europarl.europa.eu/doceo/document/CONT-AM-704734_EN.html
|
docs/2/docs/0/url |
https://www.europarl.europa.eu/doceo/document/LIBE-AD-702929_EN.html
|
docs/3 |
|
docs/2/date |
Old
2022-02-09T00:00:00New
2022-02-16T00:00:00 |
docs/2 |
|
forecasts |
|
docs/1 |
|
committees/2/rapporteur |
|
committees/1/opinion |
False
|
events/1 |
|
procedure/dossier_of_the_committee |
|
procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting committee decision |
committees/0/shadows/4 |
|
commission |
|
committees/0 |
|
committees/0 |
|